Quantcast

Latest Recombinant proteins Stories

2014-07-25 12:24:51

ALBANY, New York, July 25, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, Modern and Human Insulin) - Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume), 2013 - 2019", the global insulin market was valued at USD 19.99 billion in 2012 and is expected to grow at a CAGR of 6.1% from 2013 to 2019 to...

2014-07-23 23:23:16

The human insulin market is segmented based on types of insulin, and branded drugs available in the market. http://www.marketsandmarkets.com/Market-Reports/human-insulin-market-229295783.html. (PRWEB) July 22, 2014 The “Human Insulin Market by Product Type [Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed)], by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to 2019” provides a...

2014-07-23 12:32:02

DALLAS, July 23, 2014 /PRNewswire/ -- Expiring biologic human insulin market drugs' patents are set to create new opportunities for biosimilar drugs, which is estimated to grow at a CAGR of 35% from 2014-2019. This, as per the report titled "Human Insulin Market by Product Type (Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed), by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) -...

2014-07-16 20:22:30

LONDON, July 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Insulin Market Outlook 2018 https://www.reportbuyer.com/product/2080565/Global-Insulin-Market-Outlook-2018.html About 381 Million people suffered from diabetes in 2013 globally, which is likely to reach 591 Million by 2035. The growing number of diabetes patients at such a high pace significantly increases the demand for insulin products. The discovery of Insulin therapy has...

2014-07-08 23:09:30

Market Size - $1,136.2 million in 2013, Market Growth - CAGR of 15.0%, Market Trends– Introduction of ultra-long and ultra-fast acting insulin such as Tresiba new report by Grand View Research. View full report with TOC - http://www.grandviewresearch.com/industry-analysis/cis-insulin-market. San Francisco, California (PRWEB) July 08, 2014 The CIS market for insulin and insulin products is expected to reach USD 3,008.5 million by 2020 growing at a CAGR of 15.0%, according to a new study...

2014-07-08 08:31:22

- Toujeo dossier already accepted by EMA - PARIS, July 8, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application (NDA) for Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL), an investigational basal insulin. The acceptance of the NDA follows the acceptance of the marketing authorization dossier for Toujeo by the European Medicines Agency (EMA) for...

2014-06-30 23:11:03

ReportsnReports.com offers Human Insulin Market by Product Type (Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed), by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to 2018 research report in its store. This report is spread across 250 pages and provides 112 data tables as well as 43 figures to support the business intelligence and global human insulin market information provided in the...

2014-06-27 12:26:19

DALLAS, June 27, 2014 /PRNewswire/ -- According to the new market research report, "Human Insulin Market by Product Type (Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed), by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to 2018" published by MarketsandMarkets, The global Human Insulin Market crossed $23 Billion in 2013 and is poised to grow at a high double-digit CAGR from...

2014-06-27 08:25:26

First biosimilar insulin to receive CHMP positive opinion in the EU INDIANAPOLIS and INGELHEIM, Germany, June 27, 2014 /PRNewswire/ -- The Committee for Medicinal Products for Human Use (CHMP) today issued a positive opinion recommending approval for the investigational compound LY2963016, a new insulin glargine product, for the treatment of type 1 and type 2 diabetes. The new insulin glargine product from Eli Lilly and Company and Boehringer Ingelheim is the first biosimilar insulin...

2014-06-27 08:25:19

First biosimilar insulin to receive CHMP positive opinion in the EU INDIANAPOLIS and RIDGEFIELD, Conn., June 27, 2014 /PRNewswire/ -- The Committee for Medicinal Products for Human Use (CHMP) today issued a positive opinion recommending approval for the investigational compound LY2963016, a new insulin glargine product, for the treatment of type 1 and type 2 diabetes. The new insulin glargine product from Eli Lilly and Company (NYSE: LLY) and Boehringer Ingelheim is the first...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related